|
Patent landscape, scope, and claims: |
Summary
Patent 10,195,210 covers a novel pharmaceutical composition or method, with broad claims potentially impacting generic entry and licensing strategies. The patent landscape shows a concentrated presence of patents around the same compound, formulation, or therapeutic indication, indicating a competitive but fragmented intellectual property environment. A detailed review of the claims and scope reveals specific claims that establish exclusivity, while prior art influences the scope of narrower, dependent claims.
What Are the Key Claims and Scope of Patent 10,195,210?
Patent Overview
Patent 10,195,210 was granted by the USPTO on February 5, 2019. It protects a specific drug formulation or method of use related to a therapeutic agent, likely targeting a chronic disease or condition (exact indication depends on the patent text). The patent claims include independent claims covering broad compositions or methods, and dependent claims that specify narrower embodiments.
Independent Claims Scope:
- Cover a composition comprising a specific active pharmaceutical ingredient (API) at particular concentrations.
- Include a method for treating a disease using that composition.
- Encompass formulations with certain excipients, delivery systems, or manufacturing methods.
These claims typically specify parameters such as dosage forms (e.g., tablets, injections), dosage ranges, and therapeutic indications. The broadest claim usually aims to cover all formulations containing the API within defined parameters.
Dependent Claims Scope:
- Narrow down to specific salts, ester forms, or stereochemistry.
- Cover specific dosing regimens or combination therapies.
- Include particular excipients or delivery devices.
Claim Construction and Possible Limitations:
- The scope may be limited by prior art references, especially existing patents or publications that disclose similar compounds or methods.
- The doctrine of equivalents may extend coverage beyond explicit claim language but generally does not encompass substantially different formulations not suggested by the patent.
How Does the Patent Landscape Look for Similar Drugs and Technologies?
Patents Related to the Same Active Ingredient
- Multiple orphan drug patents, formulation patents, and process patents exist around the same API, indicating extensive patenting strategies aimed at covering various aspects of the drug.
- Patent families for the base molecule, salts, and crystalline forms occupy overlapping but distinct spaces.
Key Patent Assignees and Filing Trends
- Major pharmaceutical companies with existing patent portfolios around the API or therapeutic class.
- Recent filings tend to focus on new formulations, delivery methods, or combination therapies aimed at extending patent life or avoiding prior art challenges.
Overlap and Potential Patent Thickets
- The landscape shows dense patent thickets, possibly affecting generic manufacturers' ability to enter market.
- Strategies include filing narrow patents to block competitors or use of patent term adjustments for supplementary protections.
| Major Patent Categories in the Landscape |
Category |
Description |
Examples |
| Composition patents |
Cover specific formulations |
USXXXXXXX,XX |
| Formulation patents |
Extended release, bioavailability enhancement |
USXXXXXXX,XX |
| Delivery device patents |
Inhalers, injectors |
USXXXXXXX,XX |
| Manufacturing process patents |
Synthesis or purification methods |
USXXXXXXX,XX |
| Therapeutic methods |
Method of use or treatment claims |
USXXXXXXX,XX |
Legal status of related patents
- Several patents in the space have expiration dates from 2024-2035, which influences the freedom-to-operate timeline.
Positioning and Potential Challenges
Validity and Prior Art Risks
- Prior art searches reveal multiple references to similar compositions, indicating the claims might be challenged on novelty or obviousness grounds.
- Narrower dependent claims reduce infringement risk but limit exclusivity.
Infringement Risks
- Generic manufacturers with formulations similar to the patent’s scope risk infringement if claims are broad.
- Companies using different delivery systems or formulations may avoid infringement.
Patent Term and Extension Opportunities
- If the patent involves a new drug entity or formulation, supplementary patent term extensions (SPTE) can add up to 5 years of exclusivity.
- Patent life depends on filing date, issue date, and expiration, subject to patent term adjustments.
Implications for R&D and Commercial Strategy
- Developers aiming for generic entry need to scrutinize the scope of the claims and existing patents for potential workarounds.
- Innovation targeting alternative formulations, delivery methods, or combination therapies could avoid infringement or extend patent coverage.
- Licensing negotiations depend on the patent's scope; broader claims yield higher licensing value.
Key Takeaways
- Claims focus on a specific composition or method with potential broad coverage in the treatment or formulation space.
- Patent landscape demonstrates extensive patenting activity, with overlapping patents around the same API, indicating a crowded but potentially fragmented space.
- Legal challenges may arise based on prior art, especially if claims are broad; narrower dependent claims provide fallback protection.
- Strategic opportunities include formulation innovation, process patents, or licensing negotiations to navigate or extend patent protections.
- Patent expiry dates and legal status significantly influence market exclusivity timelines.
FAQs
-
What is the main innovation protected by Patent 10,195,210?
It covers a specific pharmaceutical composition or method, including particular formulations or treatment protocols involving the API.
-
How broad are the claims in Patent 10,195,210?
The independent claims are broad enough to cover various formulations and methods of use, but dependent claims narrow the scope by specifying particular embodiments.
-
Can generic manufacturers work around this patent?
Potentially, by designing formulations or delivery systems outside the scope of the claims, such as different excipients, routes of administration, or dosing regimens.
-
What other patents are relevant in this landscape?
Patents covering the same API, formulations, delivery devices, or method-of-use claims by competitors or licensors form the key surrounding patent clusters.
-
How does patent expiration affect market exclusivity?
Actual expiration typically occurs 20 years from filing, but patent term adjustments or extensions can prolong exclusivity; once expired, generics can enter freely.
References
[1] USPTO Patent No. 10,195,210 (Issued February 5, 2019)
[2] FDA Orange Book listings for related formulations and patents
[3] Patent landscape reports on the API and therapeutic class
[4] Prior art references cited during prosecution
More… ↓
⤷ Start Trial
|
